Ingevity Corporation NGVT

73.00 1.21 1.69% as of 25 Sep
Market cap
$2.5B
P/E
47.4×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more TTM periods

1,048.10 1,167.60 1,177.70 1,160.30
Cost of Revenue
564.20 706.10 711.70 683.10
Gross Profit
483.90 461.50 466.00 477.20
R&D Expenses
25.20 28.40 28.10 27.20
SG&A Expenses
160.90 171.20 170.00 165.40
Operating Income
207.20 (44.00) (36.60) 137.30
Non-operating Income/Expense
(32.00) (98.10) (112.90) (99.50)
Non-operating Interest Expenses
84.90 78.30 74.80 70.40
EBT
175.20 (142.10) (149.50) 37.80
Income Tax Provision
75.90 8.20 6.50 12.60
Income after Tax
99.30 (150.30) (156.00) 25.20
Net Income Common
(65.90) (167.10) (127.80) 54.00
EPS (Basic)
(1.80) (4.63) (3.50) 1.54
Gross Margin
46.17% 39.53% 39.57% 41.13%
EBIT Margin
19.77% (3.77%) (3.11%) 11.83%
EBT margin
16.72% (12.17%) (12.69%) 3.26%
Net Profit Margin
(6.29%) (14.31%) (10.85%) 4.65%
Free Cash Flow Margin
22.86% 23.73% 20.87% 13.35%
EBITDA
494.70 246.20 251.40 237.90
EBIT
207.20 (44.00) (36.60) 137.30
EPS (Diluted, from Cont. Ops)
2.73 (4.15) (4.29) 0.71
EPS (Diluted, from Disc. Ops)
0.00 0.00 0.00 0.00
EPS (Basic, Consolidated)
(1.80) (4.61) (3.48) 1.56
EPS (Basic, from Discontinued Ops)
(4.56) (0.46) 0.82 0.84
EPS (Basic, from Continuous Ops)
2.75 (4.15) (4.29) 0.73
Income from Continuous Operations
99.30 (150.30) (156.00) 25.20
Income from Discontinued Operations
(165.20) (16.80) 28.20 28.80
Consolidated Net Income/Loss
(65.90) (167.10) (127.80) 54.00
EBITDA Margin
47.20% 21.09% 21.35% 20.50%
Operating Cash Flow Margin
28.49% 28.37% 25.80% 18.18%

Fold the line items

In millions of $ except per-share values · columns are period end dates